Harald Reinhart - 13 Jul 2021 Form 4 Insider Report for Zai Lab Ltd (ZLAB)

Role
Chief Medical Officer
Signature
/s/ Bruce A. Blefeld, Attorney-in-Fact
Issuer symbol
ZLAB
Transactions as of
13 Jul 2021
Net transactions value
-$2,424,280
Form type
4
Filing time
15 Jul 2021, 20:05:45 UTC
Previous filing
17 Jun 2021
Next filing
25 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZLAB Ordinary Shares Options Exercise $144,000 +8,000 $18.00 8,000 13 Jul 2021 Direct F1
transaction ZLAB Ordinary Shares Sale $1,359,360 -8,000 -100% $169.92* 0 13 Jul 2021 Direct F1
transaction ZLAB Ordinary Shares Options Exercise $72,000 +4,000 $18.00 4,000 14 Jul 2021 Direct F1
transaction ZLAB Ordinary Shares Sale $676,440 -4,000 -100% $169.11* 0 14 Jul 2021 Direct F1
transaction ZLAB Ordinary Shares Options Exercise $71,960 +4,000 $17.99 4,000 14 Jul 2021 Direct F1
transaction ZLAB Ordinary Shares Sale $676,440 -4,000 -100% $169.11* 0 14 Jul 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZLAB Stock Options (Right to Buy) Options Exercise $0 -8,000 -15% $0.000000 44,000 13 Jul 2021 Ordinary Shares 8,000 $18.00 Direct F1, F2
transaction ZLAB Stock Options (Right to Buy) Options Exercise $0 -4,000 -9.1% $0.000000 40,000 14 Jul 2021 Ordinary Shares 4,000 $18.00 Direct F1, F2
transaction ZLAB Stock Options (Right to Buy) Options Exercise $0 -4,000 -8% $0.000000 46,000 14 Jul 2021 Ordinary Shares 4,000 $17.99 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
F2 The options vest in equal annual installments over five years beginning on 09/20/2018, the first anniversary of the date of grant.
F3 The options vest in equal annual installments over five years beginning on 11/16/2019, the first anniversary of the date of grant.